
  
    
      
        Background_NNP
        The_DT importance_NN of_IN bacterial_JJ infections_NNS that_WDT complicate_VB
        the_DT clinical_JJ course_NN of_IN patients_NNS with_IN human_JJ immunodeficiency_NN
        virus_NN (_( HIV_NNP )_) infection_NN has_VBZ been_VBN recognized_VBN since_IN the_DT
        beginning_NN of_IN the_DT AIDS_NNP epidemic_NN [_NN 1_CD 2_CD ]_NN ._. Several_JJ factors_NNS
        predispose_VB patients_NNS with_IN HIV_NNP infection_NN to_TO bacterial_JJ
        infections_NNS ._. These_DT factors_NNS include_VBP abnormalities_NNS in_IN humoral_NN
        and_CC cell-mediated_JJ immunity_NN ,_, phagocytic_JJ cell_NN dysfunction_NN ,_,
        and_CC skin_NN and_CC mucous_JJ membrane_NN defects_NNS [_NN 3_CD ]_NN ._. The_DT presence_NN
        of_IN neutropenia_NN [_NN 4_CD 5_CD ]_NN use_NN of_IN central_JJ venous_JJ catheters_NNS [_NN 4_CD
        6_CD ]_NN ,_, low_JJ CD_NNP 4_CD +_NN lymphocyte_NN count_NN ,_, and_CC intravenous_JJ drug_NN use_NN [_NN
        6_CD ]_NN are_VBP cited_VBN as_IN risk_NN factors_NNS for_IN bacteremic_JJ infections_NNS in_IN
        patients_NNS with_IN HIV_NNP infection_NN ._. Bacterial_NNP infections_NNS are_VBP
        responsible_JJ for_IN the_DT immediate_JJ cause_NN of_IN death_NN of_IN up_IN to_TO 30_CD %_NN
        of_IN patients_NNS with_IN HIV_NNP infection_NN [_NN 7_CD ]_NN ._. The_DT purpose_NN of_IN this_DT
        study_NN was_VBD to_TO describe_VB the_DT bacterial_JJ pathogens_NNS causing_VBG blood_NN
        stream_NN infection_NN ,_, identify_VBP the_DT risk_NN factors_NNS for_IN the_DT
        development_NN of_IN blood_NN stream_NN infection_NN ,_, and_CC determine_VB the_DT
        impact_NN of_IN blood_NN stream_NN infection_NN on_IN the_DT outcome_NN of_IN
        hospitalized_VBN patients_NNS with_IN HIV_NNP ._.
      
      
        Methods_NNP
        This_DT prospective_JJ ,_, observational_NN study_NN included_VBD 1_CD ,_, 225_CD
        consecutive_JJ hospital_NN admissions_NNS of_IN 599_CD adults_NNS with_IN HIV_NNP
        infection_NN treated_VBN at_IN the_DT University_NNP Medical_NNP Center_NNP ,_,
        Jacksonville_NNP ,_, Florida_NNP ,_, from_IN April_NNP 1995_CD through_IN March_NNP 1998_CD ._.
        All_DT adults_NNS with_IN HIV_NNP infection_NN who_WP were_VBD admitted_VBN to_TO the_DT
        hospital_NN were_VBD included_VBN in_IN the_DT study_NN ._. The_DT University_NNP Medical_NNP
        Center_NNP is_VBZ a_DT 528_CD -_: bed_NN ,_, inner-city_JJ teaching_NN hospital_NN
        affiliated_VBN with_IN the_DT University_NNP of_IN Florida_NNP ._. Because_IN of_IN the_DT
        hospital_NN 's_POS inner-city_JJ location_NN ,_, most_JJS of_IN the_DT patients_NNS were_VBD
        African_NNP American_NNP ._. The_DT need_NN for_IN informed_VBN consent_NN was_VBD waived_VBN
        by_IN the_DT institutional_JJ review_NN board_NN of_IN the_DT hospital_NN ._.
        The_DT isolation_NN of_IN a_DT bacterium_NN in_IN 1_CD or_CC more_JJR blood_NN cultures_NNS
        was_VBD diagnostic_JJ of_IN bacterial_JJ blood_NN stream_NN infection_NN ._. Blood_NNP
        isolates_VBZ of_IN coagulase-negative_JJ staphylococci_NN ,_, 
        Corynebacterium_NNP species_NNS ,_, 
        Bacillus_NN species_NNS ,_, 
        Propionibacterium_NNP species_NNS ,_, 
        Peptostreptococcus_NNP species_NNS ,_, 
        Clostridium_NNP species_NNS ,_, and_CC unidentified_JJ
        Gram-positive_NNP rods_NNS were_VBD considered_VBN contaminated_JJ if_IN a_DT single_JJ
        blood_NN culture_NN yielded_VBD the_DT organism_NN or_CC the_DT clinician_NN did_VBD not_RB
        initiate_VB treatment_NN ,_, considering_VBG it_PRP not_RB a_DT true_JJ infection_NN ._.
        Mycobacterial_NNP infections_NNS were_VBD excluded_VBN from_IN the_DT study_NN ._. The_DT
        place_NN of_IN acquisition_NN of_IN the_DT blood_NN stream_NN infection_NN was_VBD
        defined_VBN as_IN nosocomial_NN if_IN the_DT infection_NN developed_VBN after_IN 48_CD
        hours_NNS of_IN hospitalization_NN or_CC within_IN 14_CD days_NNS of_IN previous_JJ
        hospitalization_NN ._. We_PRP collected_VBD data_NNS on_IN age_NN ,_, sex_NN ,_, race_NN ,_,
        exposure_NN category_NN for_IN HIV_NNP infection_NN ,_, place_NN of_IN acquisition_NN ,_,
        white_JJ blood_NN cell_NN count_NN ,_, CD_NNP 4_CD +_NN lymphocyte_NN count_NN ,_, worst_JJS Acute_NNP
        Physiology_NNP and_CC Chronic_NNP Health_NNP Evaluation_NNP (_( APACHE_NNP )_) II_NNP score_NN
        within_IN 24_CD hours_NNS of_IN hospital_NN admission_NN ,_, presence_NN of_IN blood_NN
        stream_NN infection_NN ,_, intensive_JJ care_NN unit_NN admission_NN status_NN ,_,
        length_NN of_IN hospital_NN stay_NN ,_, and_CC in-hospital_JJ mortality_NN ._. The_DT
        source_NN of_IN the_DT blood_NN stream_NN infection_NN was_VBD identified_VBN by_IN the_DT
        isolation_NN of_IN the_DT same_JJ pathogenic_JJ organism_NN from_IN both_DT the_DT
        source_NN and_CC the_DT blood_NN ._. The_DT APACHE_NNP II_NNP score_NN and_CC predicted_VBD
        mortality_NN rate_NN for_IN each_DT hospital_NN admission_NN were_VBD calculated_VBN
        [_NN 8_CD ]_NN ._. The_DT standardized_JJ mortality_NN ratio_NN was_VBD determined_VBN by_IN
        dividing_VBG the_DT actual_JJ mortality_NN by_IN the_DT predicted_VBN mortality_NN ._.
        For_IN the_DT purpose_NN of_IN this_DT study_NN ,_, each_DT admission_NN was_VBD analyzed_VBN
        independently_RB ._.
        StatView_NNP 5_CD ._. 0_CD computer_NN software_NN (_( SAS_NNP Institute_NNP ,_, Cary_NNP ,_, NC_NNP )_)
        was_VBD used_VBN for_IN statistical_JJ analysis_NN ._. Each_DT mean_NN was_VBD expressed_VBN
        with_IN its_PRP$ standard_JJ deviation_NN ._. Comparisons_NNP between_IN groups_NNS
        were_VBD made_VBN using_VBG logistic_JJ regression_NN analysis_NN and_CC Student_NNP 
        t_NN ,_, Mann-_NNP Whitney_NNP 
        U_NNP ,_, Χ_NN 2_CD ,_, and_CC Fisher_NNP exact_JJ tests_NNS ._. When_WRB
        available_JJ ,_, the_DT continuity-corrected_JJ 
        P_NN values_NNS were_VBD used_VBN for_IN Χ_NN 2_CD analysis_NN ._. 
        P_NN values_NNS less_JJR than_IN 0_CD ._. 05_CD were_VBD
        considered_VBN significant_JJ ._.
      
      
        Results_NNS
        Table_NNP 1_CD provides_VBZ demographic_JJ ,_, exposure_NN category_NN ,_, and_CC
        health_NN status_NN data_NNS on_IN 1_CD ,_, 225_CD hospital_NN admissions_NNS of_IN 599_CD
        patients_NNS with_IN HIV_NNP infection_NN ._. Because_IN some_DT individuals_NNS were_VBD
        admitted_VBN more_RBR than_IN once_RB during_IN the_DT study_NN period_NN ,_, in_IN this_DT
        report_NN the_DT word_NN 
        patient_NN does_VBZ not_RB necessarily_RB mean_VB 1_CD
        unique_JJ individual_NN ._. Thirty-four_CD percent_NN of_IN the_DT African_NNP
        Americans_NNPS and_CC 67_CD %_NN of_IN the_DT Hispanics_NNPS had_VBD a_DT history_NN of_IN
        injection_NN drug_NN use_NN compared_VBN with_IN 20_CD %_NN of_IN the_DT whites_NNS (_( 
        P_NN <_NN 0_CD ._. 0001_CD )_) ._.
        In_IN the_DT 1_CD ,_, 225_CD admissions_NNS ,_, 88_CD patients_NNS (_( 7_CD %_NN )_) had_VBD 89_CD
        episodes_NNS of_IN blood_NN stream_NN infection_NN ._. Of_IN these_DT 89_CD infections_NNS ,_,
        73_CD (_( 82_CD %_NN )_) were_VBD community_NN acquired_VBN and_CC 16_CD (_( 18_CD %_NN )_) were_VBD
        nosocomial_NN ._. Twenty-one_CD of_IN the_DT 345_CD admissions_NNS (_( 6_CD %_NN )_) during_IN
        the_DT first_JJ year_NN of_IN the_DT study_NN had_VBD blood_NN stream_NN infection_NN
        compared_VBN with_IN 35_CD of_IN 435_CD admissions_NNS (_( 8_CD %_NN )_) during_IN the_DT second_JJ
        year_NN and_CC 32_CD of_IN 445_CD admissions_NNS (_( 7_CD %_NN )_) during_IN the_DT third_JJ year_NN (_( 
        P_NN =_SYM 0_CD ._. 5748_CD )_) ._. The_DT sources_NNS of_IN
        bacteremia_NN were_VBD identified_VBN in_IN 52_CD patients_NNS (_( 59_CD %_NN )_) and_CC
        included_VBD pneumonia_NN in_IN 33_CD ,_, urinary_JJ tract_NN infection_NN in_IN 12_CD ,_,
        peritonitis_NNS in_IN 2_CD ,_, and_CC cellulitis_NNS ,_, pancreatitis_NNS ,_, central_JJ
        venous_JJ catheter_NN ,_, cholangitis_NNS ,_, and_CC arthritis_NN in_IN 1_CD each_DT ._. In_IN 1_CD
        patient_NN ,_, 2_CD organisms_NNS ,_, 
        Salmonella_NNP typhi_NN and_CC 
        Klebsiella_NNP pneumoniae_NN ,_, were_VBD isolated_VBN
        from_IN the_DT blood_NN during_IN the_DT same_JJ hospitalization_NN ;_: both_DT were_VBD
        community_NN acquired_VBN ._. The_DT pathogens_NNS causing_VBG blood_NN stream_NN
        infection_NN are_VBP listed_VBN in_IN Table_NNP 2_CD ._. Six_CD patients_NNS had_VBD 2_CD
        episodes_NNS of_IN blood_NN stream_NN infection_NN during_IN the_DT study_NN period_NN ,_,
        all_DT during_IN different_JJ hospitalizations_NNS ._. One_CD patient_NN had_VBD 2_CD
        episodes_NNS of_IN 
        Pseudomonas_NNP aeruginosa_NN bacteremia_NN and_CC
        another_DT patient_NN had_VBD 2_CD episodes_NNS of_IN 
        S_NNP typhi_NN bacteremia_NN ._.
        There_EX were_VBD no_DT significant_JJ differences_NNS in_IN age_NN ,_, sex_NN ,_, and_CC
        risk_NN factors_NNS for_IN HIV_NNP infection_NN between_IN patients_NNS with_IN and_CC
        without_IN blood_NN stream_NN infection_NN (_( Table_NNP 3_LS )_) ._. The_DT median_JJ CD_NNP 4_CD
        +_NN lymphocyte_NN count_NN for_IN injection_NN drug_NN users_NNS was_VBD 0_CD ._. 08_CD ×_NN 10_CD
        9_CD /_NN L_NNP compared_VBD with_IN 0_CD ._. 06_CD ×_NN 10_CD 9_CD /_NN L_NNP for_IN noninjection_NN drug_NN users_NNS
        (_( 
        P_NN =_SYM 0_CD ._. 0042_CD )_) ._. The_DT incidence_NN of_IN blood_NN
        stream_NN infection_NN in_IN African_NNP Americans_NNPS and_CC Hispanics_NNPS was_VBD
        higher_JJR than_IN in_IN whites_NNS (_( Table_NNP 3_LS )_) ._. The_DT CD_NNP 4_CD +_NN lymphocyte_NN count_NN
        was_VBD similar_JJ and_CC the_DT APACHE_NNP II_NNP score_NN and_CC white_JJ blood_NN cell_NN
        count_NN higher_JJR in_IN patients_NNS with_IN blood_NN stream_NN infection_NN
        compared_VBN with_IN those_DT without_IN blood_NN stream_NN infection_NN (_( Table_NNP
        3_LS )_) ._. In_IN patients_NNS with_IN blood_NN stream_NN infection_NN ,_, 78_CD %_NN had_VBD a_DT CD_NNP 4_CD
        +_NN lymphocyte_NN count_NN less_JJR than_IN 0_CD ._. 2_CD ×_NN 10_CD 9_CD /_NN L_NNP compared_VBD with_IN 74_CD %_NN
        of_IN the_DT patients_NNS without_IN blood_NN stream_NN infection_NN (_( 
        P_NN =_SYM 0_CD ._. 5649_CD )_) ._. The_DT predicted_VBN mortality_NN
        rate_NN of_IN patients_NNS with_IN blood_NN stream_NN infection_NN was_VBD higher_JJR
        than_IN that_DT of_IN patients_NNS without_IN blood_NN stream_NN infection_NN (_( 37_CD %_NN
        vs_NNS ._. 21_CD %_NN ;_: 
        P_NN <_NN 0_CD ._. 0001_CD )_) ._. Twenty-six_NNP percent_NN of_IN
        the_DT patients_NNS with_IN blood_NN stream_NN infection_NN had_VBD a_DT white_JJ blood_NN
        cell_NN count_NN less_JJR than_IN 4_CD ×_NN 10_CD 9_CD /_NN L_NNP compared_VBD with_IN 36_CD %_NN of_IN the_DT
        patients_NNS without_IN blood_NN stream_NN infection_NN (_( 
        P_NN =_SYM 0_CD ._. 0810_CD )_) ._.
        The_DT differences_NNS in_IN the_DT length_NN of_IN hospital_NN stay_NN ,_,
        intensive_JJ care_NN unit_NN admission_NN rate_NN ,_, and_CC in-hospital_JJ
        mortality_NN between_IN patients_NNS with_IN and_CC patients_NNS without_IN blood_NN
        stream_NN infection_NN are_VBP listed_VBN in_IN Table_NNP 4_CD ._. Compared_VBN with_IN
        patients_NNS without_IN blood_NN stream_NN infection_NN ,_, the_DT in-hospital_JJ
        mortality_NN and_CC intensive_JJ care_NN unit_NN admission_NN rates_NNS of_IN
        patients_NNS with_IN blood_NN stream_NN infection_NN were_VBD higher_JJR and_CC their_PRP$
        length_NN of_IN hospital_NN stay_NN longer_RBR ._. The_DT standardized_JJ mortality_NN
        ratios_NNS of_IN patients_NNS with_IN and_CC without_IN blood_NN stream_NN infection_NN
        were_VBD 0_CD ._. 486_CD and_CC 0_CD ._. 213_CD ,_, respectively_RB ._. Multiple_NNP logistic_JJ
        regression_NN analysis_NN using_VBG a_DT model_NN consisting_VBG of_IN mortality_NN
        as_IN a_DT dependent_JJ variable_JJ and_CC APACHE_NNP II_NNP score_NN and_CC presence_NN of_IN
        blood_NN stream_NN infection_NN as_IN independent_JJ variables_NNS showed_VBD that_IN
        both_DT blood_NN stream_NN infection_NN (_( odds_NNS ratio_NN ,_, 2_CD ._. 29_CD ;_: 95_CD %_NN CI_NNP ,_,
        1_CD ._. 13_CD -_: 4_CD ._. 62_CD )_) and_CC APACHE_NNP II_NNP score_NN (_( odds_NNS ratio_NN ,_, 1_CD ._. 18_CD ;_: 95_CD %_NN CI_NNP ,_,
        1_CD ._. 14_CD -_: 1_CD ._. 23_CD )_) were_VBD independently_RB associated_VBN with_IN mortality_NN ._.
        Among_IN patients_NNS with_IN blood_NN stream_NN infection_NN ,_, survivors_NNS had_VBD a_DT
        lower_JJR APACHE_NNP II_NNP score_NN than_IN nonsurvivors_NNS (_( median_JJ ,_, 17_CD vs_NNS ._.
        27_CD ._. 5_LS ;_: 
        P_NN <_NN 0_CD ._. 0001_CD )_) ,_, but_CC did_VBD not_RB
        significantly_RB differ_VB in_IN CD_NNP 4_CD +_NN lymphocyte_NN count_NN (_( median_JJ ,_,
        0_CD ._. 077_CD vs_NNS ._. 0_CD ._. 011_CD ×_NN 10_CD 9_CD /_NN L_NNP ;_: 
        P_NN =_SYM 0_CD ._. 0574_CD )_) ._. Two_CD of_IN the_DT 34_CD patients_NNS
        (_( 6_CD %_NN )_) with_IN gram-negative_JJ blood_NN stream_NN infection_NN died_VBD
        compared_VBN with_IN 14_CD of_IN 54_CD patients_NNS (_( 26_CD %_NN )_) with_IN gram-positive_JJ
        blood_NN stream_NN infection_NN (_( 
        P_NN =_SYM 0_CD ._. 0366_CD )_) ._. The_DT mortality_NN associated_VBN
        with_IN each_DT pathogen_NN causing_VBG blood_NN stream_NN infection_NN is_VBZ listed_VBN
        in_IN Table_NNP 5_CD ._. Among_IN the_DT 88_CD patients_NNS with_IN blood_NN stream_NN
        infection_NN ,_, multiple_JJ logistic_JJ regression_NN analysis_NN using_VBG a_DT
        model_NN of_IN mortality_NN as_IN a_DT dependent_JJ variable_JJ and_CC APACHE_NNP II_NNP
        score_NN ,_, CD_NNP 4_CD +_NN lymphocyte_NN count_NN ,_, and_CC place_NN of_IN acquisition_NN of_IN
        the_DT infection_NN as_IN independent_JJ variables_NNS showed_VBD that_IN higher_JJR
        APACHE_NNP II_NNP scores_NNS (_( odds_NNS ratio_NN ,_, 1_CD ._. 25_CD ;_: 95_CD %_NN CI_NNP ,_, 1_CD ._. 12_CD -_: 1_CD ._. 40_CD )_) and_CC
        nosocomial_NN acquisition_NN (_( odds_NNS ratio_NN ,_, 5_CD ._. 85_CD ;_: 95_CD %_NN CI_NNP ,_,
        1_CD ._. 25_CD -_: 27_CD ._. 31_CD )_) ,_, but_CC not_RB CD_NNP 4_CD +_NN lymphocyte_NN count_NN (_( odds_NNS ratio_NN ,_,
        1_CD ._. 00_CD ;_: 95_CD %_NN CI_NNP ,_, 0_CD ._. 99_CD -_: 1_CD ._. 00_CD )_) ,_, were_VBD independently_RB associated_VBN
        with_IN mortality_NN ._. The_DT intensive_JJ care_NN unit_NN admission_NN rate_NN of_IN
        patients_NNS with_IN community-acquired_JJ blood_NN stream_NN infection_NN was_VBD
        similar_JJ to_TO that_DT of_IN patients_NNS with_IN nosocomial_NN blood_NN stream_NN
        infection_NN (_( 19_CD %_NN vs_NNS ._. 44_CD %_NN ;_: 
        P_NN =_SYM 0_CD ._. 0820_CD )_) ._. The_DT median_JJ length_NN of_IN
        hospital_NN stay_NN of_IN patients_NNS with_IN community-acquired_JJ blood_NN
        stream_NN infection_NN was_VBD 5_CD days_NNS compared_VBN with_IN 8_CD ._. 5_CD days_NNS for_IN
        patients_NNS with_IN nosocomial_NN blood_NN stream_NN infection_NN (_( 
        P_NN =_SYM 0_CD ._. 0477_CD )_) ._. The_DT mortality_NN rate_NN of_IN
        patients_NNS with_IN blood_NN stream_NN infection_NN was_VBD 6_CD %_NN during_IN the_DT
        third_JJ year_NN of_IN the_DT study_NN compared_VBN with_IN 14_CD %_NN and_CC 31_CD %_NN during_IN
        the_DT first_JJ and_CC second_JJ years_NNS ,_, respectively_RB (_( 
        P_NN =_SYM 0_CD ._. 0247_CD )_) ._.
      
      
        Discussion_NNP
        This_DT study_NN describes_VBZ the_DT incidence_NN of_IN bacterial_JJ blood_NN
        stream_NN infection_NN as_RB well_RB as_IN its_PRP$ causative_JJ pathogens_NNS ,_, risk_NN
        factors_NNS for_IN its_PRP$ development_NN ,_, and_CC its_PRP$ impact_NN on_IN outcome_NN in_IN
        hospitalized_VBN patients_NNS with_IN HIV_NNP ._. Blood_NNP stream_NN infection_NN
        developed_VBN in_IN 7_CD %_NN of_IN the_DT patients_NNS ;_: of_IN these_DT infections_NNS ,_, 82_CD %_NN
        were_VBD community_NN acquired_VBN and_CC 18_CD %_NN were_VBD nosocomial_NN ._. The_DT
        incidence_NN rate_NN of_IN blood_NN stream_NN infection_NN was_VBD higher_JJR in_IN
        African_NNP Americans_NNPS and_CC Hispanics_NNPS compared_VBD with_IN whites_NNS ._. There_EX
        were_VBD no_DT significant_JJ differences_NNS in_IN sex_NN ,_, age_NN ,_, and_CC CD_NNP 4_CD
        +_NN lymphocyte_NN count_NN between_IN patients_NNS with_IN and_CC patients_NNS
        without_IN blood_NN stream_NN infection_NN ._. The_DT APACHE_NNP II_NNP score_NN and_CC
        white_JJ blood_NN cell_NN count_NN of_IN patients_NNS with_IN blood_NN stream_NN
        infection_NN were_VBD higher_JJR than_IN those_DT of_IN patients_NNS without_IN blood_NN
        stream_NN infection_NN ._. The_DT mortality_NN and_CC ICU_NNP admission_NN rates_NNS of_IN
        patients_NNS with_IN blood_NN stream_NN infection_NN were_VBD higher_JJR and_CC their_PRP$
        length_NN of_IN hospital_NN stay_NN longer_RBR than_IN those_DT of_IN patients_NNS
        without_IN blood_NN stream_NN infection_NN ._. Among_IN patients_NNS with_IN blood_NN
        stream_NN infection_NN ,_, the_DT mortality_NN rate_NN of_IN the_DT
        community-acquired_JJ group_NN was_VBD lower_JJR than_IN that_DT of_IN the_DT
        nosocomial_NN group_NN ._.
        Bacteremia_NNP is_VBZ more_RBR common_JJ in_IN hospitalized_VBN HIV-positive_NNP
        patients_NNS than_IN in_IN HIV-negative_NNP patients_NNS [_NN 9_CD ]_NN ._. The_DT
        incidence_NN of_IN nonmycobacterial_NN bacteremias_NNS in_IN hospitalized_VBN
        patients_NNS with_IN HIV_NNP ranges_NNS from_IN 2_CD %_NN to_TO 9_CD %_NN [_NN 10_CD 11_CD 12_CD ]_NN ._. Most_JJS
        blood_NN stream_NN infections_NNS in_IN patients_NNS with_IN HIV_NNP are_VBP community_NN
        acquired_VBD [_NN 13_CD 14_CD ]_NN ._. In_IN developed_VBN countries_NNS ,_, the_DT incidence_NN
        rate_NN of_IN HIV-associated_NNP bacteremia_NN has_VBZ declined_VBN after_IN the_DT
        introduction_NN of_IN highly_RB active_JJ antiretroviral_NN therapy_NN
        (_( HAART_NNP )_) [_NN 14_CD 15_CD ]_NN ._. In_IN the_DT present_JJ study_NN ,_, the_DT incidence_NN of_IN
        blood_NN stream_NN infection_NN among_IN hospitalized_VBN patients_NNS with_IN HIV_NNP
        was_VBD 7_CD %_NN ,_, and_CC most_JJS of_IN these_DT infections_NNS were_VBD community_NN
        acquired_VBN ._. Despite_IN the_DT availability_NN of_IN HAART_NNP during_IN the_DT
        later_JJ period_NN of_IN our_PRP$ study_NN ,_, we_PRP did_VBD not_RB find_VB a_DT decline_NN in_IN the_DT
        rate_NN of_IN bacteremia_NN in_IN our_PRP$ patient_NN population_NN ._. However_RB ,_, the_DT
        mortality_NN rate_NN of_IN the_DT patients_NNS with_IN blood_NN stream_NN infection_NN
        declined_VBD during_IN the_DT third_JJ year_NN of_IN the_DT study_NN ,_, reflecting_VBG the_DT
        potential_JJ benefit_NN of_IN HAART_NNP ._.
        African_NNP American_JJ race_NN ,_, Hispanic_JJ race_NN ,_, and_CC high_JJ APACHE_NNP II_NNP
        score_NN were_VBD found_VBN to_TO be_VB risk_NN factors_NNS for_IN blood_NN stream_NN
        infection_NN in_IN hospitalized_VBN patients_NNS with_IN HIV_NNP infection_NN in_IN
        the_DT present_JJ study_NN ._. Because_IN there_EX were_VBD only_RB few_JJ Hispanics_NNPS in_IN
        the_DT present_JJ study_NN and_CC the_DT African_NNP Americans_NNPS were_VBD more_RBR
        likely_JJ than_IN the_DT whites_NNS to_TO be_VB injection_NN drug_NN users_NNS ,_, we_PRP do_VBP
        not_RB think_VB there_EX is_VBZ an_DT independent_JJ association_NN between_IN race_NN
        and_CC bacteremia_NN ._. Previous_JJ studies_NNS have_VBP shown_VBN injection_NN drug_NN
        use_NN to_TO be_VB a_DT risk_NN factor_NN for_IN bacteremia_NN [_NN 6_CD 14_CD ]_NN ._. However_RB ,_,
        like_IN the_DT study_NN by_IN Tumbarello_NNP et_CC al_NN ._. [_NN 16_CD ]_NN ,_, our_PRP$ study_NN did_VBD
        not_RB find_VB injection_NN drug_NN use_NN to_TO be_VB a_DT risk_NN factor_NN for_IN blood_NN
        stream_NN bacterial_JJ infection_NN ._. The_DT earlier_JJR stage_NN of_IN HIV_NNP
        infection_NN in_IN the_DT injection_NN drug_NN users_NNS in_IN our_PRP$ study_NN may_MD
        explain_VB their_PRP$ lower_JJR bacteremia_NN rate_NN ._. Neutropenia_NNP is_VBZ
        reported_VBN to_TO be_VB a_DT risk_NN factor_NN for_IN the_DT development_NN of_IN
        bacterial_JJ infection_NN in_IN patients_NNS with_IN HIV_NNP infection_NN [_NN 4_CD 5_CD 6_CD
        14_CD 16_CD ]_NN ._. However_RB ,_, in_IN our_PRP$ study_NN ,_, neither_DT the_DT prevalence_NN of_IN
        leukopenia_NN nor_CC the_DT total_JJ white_JJ blood_NN cell_NN count_NN was_VBD lower_JJR
        in_IN patients_NNS with_IN blood_NN stream_NN bacterial_JJ infection_NN compared_VBN
        with_IN patients_NNS without_IN blood_NN stream_NN bacterial_JJ infection_NN ._. In_IN
        fact_NN ,_, the_DT white_JJ blood_NN cell_NN count_NN was_VBD higher_JJR in_IN patients_NNS
        with_IN than_IN in_IN patients_NNS without_IN bacterial_JJ blood_NN stream_NN
        infection_NN ._. Unlike_IN other_JJ studies_NNS ,_, which_WDT showed_VBD the_DT CD_NNP 4_CD
        +_NN lymphocyte_NN count_NN to_TO be_VB low_JJ in_IN HIV-positive_NNP patients_NNS with_IN
        blood_NN stream_NN bacterial_JJ infection_NN [_NN 6_CD 16_CD ]_NN ,_, the_DT CD_NNP 4_CD
        +_NN lymphocyte_NN count_NN did_VBD not_RB differ_VB between_IN patients_NNS with_IN and_CC
        patients_NNS without_IN bacterial_JJ blood_NN stream_NN infection_NN in_IN the_DT
        present_JJ study_NN ._. The_DT lack_NN of_IN association_NN between_IN bacteremia_NN
        and_CC low_JJ CD_NNP 4_CD +_NN lymphocyte_NN count_NN or_CC leukopenia_NN in_IN the_DT present_JJ
        study_NN may_MD reflect_VB the_DT earlier_JJR stage_NN of_IN HIV_NNP infection_NN in_IN our_PRP$
        patient_NN population_NN ._.
        Previous_JJ studies_NNS have_VBP shown_VBN the_DT presence_NN of_IN central_JJ
        venous_JJ catheters_NNS to_TO be_VB a_DT risk_NN factor_NN for_IN bacterial_JJ blood_NN
        stream_NN infection_NN [_NN 4_CD 6_CD 11_CD 14_CD 16_CD 17_CD ]_NN ._. In_IN the_DT present_JJ
        study_NN ,_, an_DT intravascular_NN catheter_NN was_VBD the_DT source_NN of_IN the_DT
        blood_NN stream_NN infection_NN in_IN only_RB 1_CD patient_NN ;_: this_DT was_VBD probably_RB
        due_JJ to_TO infrequent_JJ use_NN of_IN central_JJ venous_JJ catheters_NNS and_CC
        shorter_JJR length_NN of_IN hospital_NN stay_NN ._. As_IN in_IN the_DT study_NN by_IN
        Tumbarello_NNP et_CC al_NN ._. [_NN 14_CD ]_NN ,_, higher_JJR severity_NN of_IN illness_NN ,_,
        measured_VBN by_IN APACHE_NNP II_NNP score_NN ,_, was_VBD associated_VBN in_IN the_DT present_JJ
        study_NN with_IN the_DT development_NN of_IN bacterial_JJ blood_NN stream_NN
        infection_NN ._.
        The_DT common_JJ sources_NNS of_IN blood_NN stream_NN infection_NN in_IN patients_NNS
        with_IN HIV_NNP infection_NN include_VBP the_DT lungs_NNS ,_, skin_NN ,_, subcutaneous_JJ
        tissue_NN ,_, and_CC intravascular_NN catheters_NNS [_NN 12_CD 13_CD 18_CD 19_CD ]_NN ._. In_IN
        the_DT present_JJ study_NN ,_, the_DT most_RBS common_JJ source_NN of_IN bacteremia_NN was_VBD
        pneumonia_NN ._.
        Gram-positive_NNP bacteria_NNS are_VBP responsible_JJ for_IN most_JJS of_IN the_DT
        bacteremias_NNS in_IN hospitalized_VBN HIV-positive_NNP patients_NNS [_NN 14_CD ]_NN ._.
        More_RBR gram-positive_JJ than_IN gram-negative_JJ organisms_NNS were_VBD
        isolated_VBN from_IN the_DT blood_NN stream_NN of_IN our_PRP$ subjects_NNS ._. Many_JJ
        studies_NNS have_VBP shown_VBN 
        Staphylococcus_NNP species_NNS to_TO be_VB the_DT most_RBS
        common_JJ isolates_VBZ in_IN blood_NN [_NN 6_CD 11_CD 13_CD 16_CD 20_CD ]_NN ._. In_IN our_PRP$ study_NN 
        Streptococcus_NNP pneumoniae_NN was_VBD the_DT most_RBS
        common_JJ isolate_VB ._. The_DT rate_NN of_IN pneumococcal_NN bacteremia_NN is_VBZ
        about_IN 100_CD -_: fold_VB higher_JJR in_IN patients_NNS with_IN than_IN in_IN patients_NNS
        without_IN HIV_NNP infection_NN [_NN 21_CD ]_NN ._. Because_IN most_JJS of_IN the_DT blood_NN
        stream_NN infections_NNS were_VBD community_NN acquired_VBN and_CC the_DT most_RBS
        common_JJ source_NN of_IN infection_NN was_VBD pneumonia_NN ,_, 
        Staphylococci_NNP were_VBD less_RBR frequent_JJ than_IN
        
        S_NNP pneumoniae_NN and_CC 
        Escherichia_NNP coli_NNS ._.
        
        P_NN aeruginosa_NN is_VBZ being_VBG recognized_VBN more_RBR
        frequently_RB as_IN causing_VBG both_DT community-acquired_JJ and_CC
        nosocomial_NN bacteremia_NN in_IN patients_NNS with_IN HIV_NNP infection_NN [_NN 13_CD
        16_CD 18_CD 20_CD 22_CD 23_CD ]_NN ._. Hospitalization_NNP ,_, neutropenia_NN ,_, antibiotic_JJ
        therapy_NN ,_, steroid_NN use_NN ,_, and_CC low_JJ CD_NNP 4_CD +_NN lymphocyte_NN count_NN are_VBP
        risk_NN factors_NNS for_IN 
        P_NN aeruginosa_NN bacteremia_NN in_IN patients_NNS
        with_IN HIV_NNP infection_NN [_NN 22_CD 24_CD ]_NN ._. Previously_RB ,_, we_PRP reported_VBD that_DT
        
        P_NN aeruginosa_NN is_VBZ the_DT most_RBS common_JJ
        pathogen_NN causing_VBG bacterial_JJ pneumonia_NN in_IN our_PRP$ patients_NNS [_NN 25_CD ]_NN
        ._. However_RB ,_, compared_VBN with_IN pneumococcal_NN pneumonia_NN ,_, 
        Pseudomonas_NNP pneumonia_NN is_VBZ less_RBR likely_JJ
        to_TO be_VB associated_VBN with_IN bacteremia_NN [_NN 25_CD ]_NN ._. The_DT annual_JJ
        incidence_NN rate_NN of_IN 
        P_NN aeruginosa_NN infection_NN in_IN patients_NNS
        with_IN HIV_NNP infection_NN is_VBZ estimated_VBN to_TO be_VB 2_CD ._. 51_CD cases_NNS per_IN 100_CD
        admissions_NNS [_NN 22_CD ]_NN ._. 
        P_NN aeruginosa_NN has_VBZ been_VBN reported_VBN to_TO be_VB
        the_DT causative_JJ agent_NN of_IN 7_CD ._. 6_CD %_NN to_TO 18_CD %_NN of_IN bacteremias_NNS in_IN
        hospitalized_VBN patients_NNS with_IN HIV_NNP infection_NN [_NN 14_CD 16_CD 20_CD ]_NN ._. In_IN
        the_DT present_JJ study_NN ,_, 
        P_NN aeruginosa_NN was_VBD responsible_JJ for_IN 6_CD %_NN
        of_IN the_DT bacteremias_NNS ._.
        In_IN patients_NNS with_IN HIV_NNP infection_NN ,_, although_IN bacteremia_NN in_IN
        general_NN is_VBZ more_RBR frequently_RB associated_VBN with_IN growth_NN of_IN
        gram-positive_JJ pathogens_NNS ,_, genitourinary_JJ sepsis_NN is_VBZ more_RBR
        frequently_RB related_VBN to_TO the_DT detection_NN of_IN gram-negative_JJ
        bacteria_NNS [_NN 26_CD ]_NN ._. Our_PRP$ finding_NN of_IN 
        E_NNP coli_NNS to_TO be_VB the_DT most_RBS common_JJ
        gram-negative_JJ organism_NN differs_VBZ from_IN findings_NNS in_IN previous_JJ
        studies_NNS ._. In_IN a_DT recent_JJ study_NN of_IN blood_NN stream_NN infection_NN of_IN
        hospitalized_VBN patients_NNS with_IN HIV_NNP ,_, 
        E_NNP coli_NNS was_VBD not_RB even_RB mentioned_VBN among_IN
        the_DT common_JJ etiologic_JJ agents_NNS [_NN 14_CD ]_NN ._. In_IN the_DT present_JJ study_NN a_DT
        significant_JJ number_NN of_IN the_DT patients_NNS with_IN blood_NN stream_NN
        infection_NN were_VBD women_NNS ,_, who_WP are_VBP at_IN higher_JJR risk_NN for_IN
        genitourinary_JJ infection_NN ._. The_DT relatively_RB high_JJ number_NN of_IN
        women_NNS may_MD explain_VB the_DT high_JJ rates_NNS of_IN 
        E_NNP coli_NNS blood_NN stream_NN infection_NN in_IN our_PRP$
        study_NN ._.
        The_DT present_JJ study_NN showed_VBD that_IN the_DT presentation_NN with_IN or_CC
        the_DT development_NN of_IN blood_NN stream_NN infection_NN in_IN hospitalized_VBN
        patients_NNS with_IN HIV_NNP leads_VBZ to_TO poor_JJ outcome_NN ,_, as_IN evidenced_VBN by_IN
        increased_VBN mortality_NN ,_, length_NN of_IN hospital_NN stay_NN ,_, and_CC intensive_JJ
        care_NN unit_NN admission_NN rate_NN ._. Hospital_NN mortality_NN rates_NNS of_IN
        HIV-positive_NNP patients_NNS with_IN blood_NN stream_NN infection_NN range_NN
        from_IN 9_CD %_NN to_TO 63_CD %_NN [_NN 6_CD 9_CD 11_CD 12_CD 13_CD 14_CD 16_CD ]_NN ._. In_IN the_DT present_JJ
        study_NN ,_, the_DT hospital_NN mortality_NN rate_NN of_IN patients_NNS with_IN blood_NN
        stream_NN infection_NN was_VBD 16_CD %_NN ._. Among_IN patients_NNS with_IN blood_NN stream_NN
        infection_NN ,_, we_PRP found_VBD the_DT association_NN of_IN increased_VBN mortality_NN
        with_IN high_JJ APACHE_NNP II_NNP score_NN and_CC hospital_NN acquisition_NN of_IN the_DT
        infection_NN ,_, but_CC not_RB with_IN low_JJ CD_NNP 4_CD +_NN lymphocyte_NN count_NN ._. Because_IN
        nosocomial_NN bacteremia_NN is_VBZ likely_JJ to_TO develop_VB in_IN patients_NNS with_IN
        a_DT complicated_VBN hospital_NN course_NN and_CC lead_VB to_TO multiple_JJ organ_NN
        dysfunction_NN ,_, its_PRP$ association_NN with_IN an_DT increased_VBN mortality_NN
        rate_NN is_VBZ not_RB surprising_JJ ._. Previous_JJ studies_NNS of_IN HIV-positive_NNP
        patients_NNS with_IN blood_NN stream_NN infection_NN have_VBP shown_VBN that_IN a_DT high_JJ
        APACHE_NNP II_NNP score_NN predicts_VBZ an_DT increased_VBN risk_NN of_IN death_NN [_NN 14_CD 27_CD
        ]_NN ._. Although_IN we_PRP did_VBD not_RB find_VB a_DT significant_JJ association_NN
        between_IN mortality_NN and_CC CD_NNP 4_CD +_NN lymphocyte_NN count_NN ,_, a_DT previous_JJ
        study_NN showed_VBD that_IN a_DT low_JJ CD_NNP 4_CD +_NN lymphocyte_NN count_NN is_VBZ associated_VBN
        with_IN increased_VBN mortality_NN in_IN patients_NNS with_IN nosocomial_NN blood_NN
        stream_NN infection_NN [_NN 27_CD ]_NN ._.
        Our_PRP$ study_NN has_VBZ several_JJ limitations_NNS ._. The_DT risk_NN factors_NNS for_IN
        HIV_NNP infection_NN were_VBD not_RB identified_VBN in_IN 36_CD %_NN ,_, most_RBS probably_RB
        because_IN of_IN the_DT health_NN care_NN providers_NNS '_POS and_CC patients_NNS '_POS lack_NN of_IN
        openness_NN with_IN regard_NN to_TO sexual_JJ activity_NN ._. Because_IN we_PRP were_VBD
        unable_JJ to_TO document_VB the_DT patients_NNS '_POS antiretroviral_NN therapy_NN and_CC
        previous_JJ antimicrobial_NN treatment_NN or_CC chemoprophylaxis_NNS ,_, we_PRP
        could_MD not_RB assess_VB their_PRP$ impact_NN on_IN the_DT incidence_NN ,_, etiology_NN ,_,
        and_CC outcome_NN of_IN bacterial_JJ blood_NN stream_NN infection_NN ._. In_IN many_JJ
        patients_NNS ,_, the_DT source_NN of_IN the_DT blood_NN stream_NN infection_NN was_VBD not_RB
        identified_VBN ._. Finally_RB ,_, because_IN the_DT study_NN was_VBD limited_VBN to_TO a_DT
        single_JJ center_NN ,_, the_DT results_NNS may_MD not_RB apply_VB to_TO other_JJ patient_NN
        populations_NNS ._.
      
      
        Conclusions_NNP
        Bacteremia_NNP occurs_VBZ in_IN 7_CD %_NN of_IN adult_NN patients_NNS with_IN HIV_NNP
        infection_NN who_WP require_VBP admission_NN to_TO the_DT hospital_NN ._. Most_JJS of_IN
        the_DT bacteremias_NNS are_VBP community_NN acquired_VBN ._. The_DT most_RBS common_JJ
        gram-positive_JJ organism_NN isolated_VBN from_IN the_DT blood_NN stream_NN of_IN
        patients_NNS with_IN HIV_NNP infection_NN is_VBZ 
        S_NNP pneumoniae_NN ,_, and_CC the_DT most_RBS common_JJ
        gram-negative_JJ organism_NN is_VBZ 
        E_NNP coli_NNS ._. The_DT APACHE_NNP II_NNP score_NN of_IN
        patients_NNS with_IN blood_NN stream_NN infection_NN is_VBZ higher_JJR than_IN that_DT of_IN
        patients_NNS without_IN blood_NN stream_NN infection_NN ._. The_DT presence_NN of_IN
        blood_NN stream_NN infection_NN is_VBZ associated_VBN with_IN an_DT increased_VBN
        mortality_NN rate_NN ,_, length_NN of_IN hospital_NN stay_NN ,_, and_CC intensive_JJ care_NN
        unit_NN admission_NN rate_NN ._. Recognition_NNP of_IN the_DT incidence_NN ,_,
        etiology_NN ,_, and_CC risk_NN factors_NNS of_IN blood_NN stream_NN infection_NN in_IN
        patients_NNS with_IN HIV_NNP infection_NN can_MD lead_VB to_TO preventive_JJ and_CC
        therapeutic_JJ measures_NNS that_WDT may_MD reduce_VB the_DT associated_VBN
        increased_VBN mortality_NN and_CC morbidity_NN ._.
      
      
        Competing_VBG interests_NNS
        None_NN declared_VBD ._.
      
    
  
